The PMM2 gene helps your body attach small sugar chains to proteins, a step many cells need to work properly. If the gene does not work well, protein handling across the body can be disrupted, which may lead to PMM2-CDG, a condition that often affects growth, movement, learning, feeding, and sometimes the liver, blood clotting, or vision. Understanding this gene can help you make sense of why one genetic change can affect several body systems at once.
What is a gene?
Genes are sections of DNA that give your cells instructions for making molecules or directing activities in the body. Some genes carry the code for proteins, which do much of the work inside cells. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, and medicines. More information on this topic is available in the LearnHub.
Overview
PMM2Gene function
What if the gene works
The PMM2 gene helps cells make mannose-1-phosphate, a building block used to attach sugar chains to proteins. This supports normal protein folding, transport, and function throughout the body.
Risk
What if the gene does not work
Variants in the PMM2 gene can cause PMM2-CDG, which often affects development, muscle tone, balance, growth, and organs such as the liver. Effects can range from milder to more severe, and variant type may influence symptom timing and breadth.
Treatment
What does that mean for your treatment
A pathogenic variant in the PMM2 gene does not yet have a treatment that corrects the underlying cause. In PMM2 related disease, acetazolamide can help some people with cerebellar symptoms such as unsteady walking, tremor, or eye movement problems, so it may affect drug choice when these symptoms are present. Care otherwise is mainly symptom based and supportive.
Conditions associated with PMM2
Gene function
What if the gene works
Many everyday cell jobs depend on proteins being finished with the right sugar tags. The PMM2 gene helps make an important sugar building block for that process. This supports how proteins fold, travel, and work across the body.
Inside your cells, PMM2 converts mannose-6-phosphate into mannose-1-phosphate. That step supplies a key sugar building block used to make larger sugar chains for many proteins.
The PMM2 gene supports protein glycosylation, a normal process that adds small sugar chains to proteins. These sugar tags help many proteins fold into the right shape and reach the place where they are needed. This is a central part of PMM2 gene function in protein glycosylation.
Because sugar-tagged proteins are used almost everywhere, PMM2 supports routine cell work across many organs. This includes protein stability, cell communication, and the handling of signals at the cell surface.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effects and are simply part of natural genetic variation. In some cases, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In discussions of PMM2 gene variants and enzyme activity, most changes lower how much phosphomannomutase 2 a cell can use, reduce its stability, or weaken its activity, which disrupts glycosylation (the process of attaching sugar chains to proteins). Some variants are milder and leave partial activity, while more severe variants can leave very little. In PMM2-CDG, this difference in residual activity often relates to how early features appear and how broad their impact may be.
How variants are linked to conditions
Pathogenic variants in the PMM2 gene cause PMM2-CDG, a rare inherited condition also called phosphomannomutase 2 congenital disorder of glycosylation, when both copies of the gene carry pathogenic variants. People with PMM2-CDG may have developmental delay, low muscle tone, balance and coordination problems, feeding difficulties, and liver or clotting issues, with severity varying widely. Rarely, specific PMM2 variants have also been linked to a condition with excess insulin and polycystic kidneys.
A variant is not necessarily a diagnosis
Genetic variants are a common and normal feature of human biology. Most do not directly affect health and simply reflect natural variation among people. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when more than one gene and environmental factors play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For PMM2, risk is mainly changed by family genetics rather than lifestyle. A child is at risk of PMM2-related illness only if they inherit a nonworking copy of the gene from both parents, so risk is higher when both parents are carriers or when there is a family history.
Inheritance of PMM2 variants
PMM2-related conditions follow an autosomal recessive pattern. In practical terms, the PMM2 gene inheritance pattern usually means a child inherits one PMM2 variant from each parent. Parents who carry one variant are often unaffected, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child who inherits neither variant. Because the PMM2 gene is on chromosome 16, this inheritance pattern is the same for boys and girls.
What does my PMM2 result mean for my family?
For families with a PMM2-related condition, parents are usually healthy carriers, and brothers or sisters may also be affected or be carriers. Close relatives may also carry a PMM2 change without knowing it. This can matter for family planning, because relatives who carry a PMM2 change could pass it on to their children if their partner is also a carrier.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for PMM2 variants usually uses a blood or saliva sample, which a lab analyzes to look for changes in the PMM2 gene. It can help confirm PMM2-CDG when symptoms fit, or show whether a relative carries a known family variant.
When should I consider getting a genetic test?
Genetic testing for the PMM2 gene may be worth considering when a child has features that fit PMM2-CDG, such as developmental delay, low muscle tone, feeding or growth problems, balance trouble, or unexplained liver and hormone issues. Testing can also help when PMM2-CDG runs in the family or for carrier testing before pregnancy.
A genetic result is only one part of your health story
Genetic results can provide meaningful insight, but how much they reveal depends on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood along with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can help guide treatment decisions that are more informed and more personalized. More detail on this topic is available in the LearnHub.
Drugs influenced by the PMM2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting medication response, so any concerns about side effects, new symptoms, or how a treatment is working are best discussed with your doctor.
History
The PMM2 gene became part of medical genetics history through work on congenital disorders of glycosylation, a group of inherited conditions that affect how the body attaches sugar chains to proteins. In the 1980s and 1990s, doctors recognized a recurring pattern of symptoms in infants and children that had not yet been clearly explained. From these first observations, research expanded steadily. Scientists later traced the most common form, long known as CDG-Ia, to variants in the PMM2 gene, which helped bring order to a confusing set of rare diagnoses. This discovery gave families a clearer name for the condition and improved genetic testing. Over time, the condition became more commonly known as PMM2-CDG, reflecting the gene linked to it.